Annual Congress Vienna 2012

Saturday, 01.09.2012
Sunday, 02.09.2012
Monday, 03.09.2012
Tuesday, 04.09.2012
Wednesday, 05.09.2012

Citations should be made in the following way: Authors. Title. Eur Respir J 2012; 40: Suppl. 56, abstract number.



Nanosafety: human health risk assessment

Symposium
Chairs: P. Gehr (Bern, Switzerland), T. Tetley (London, United Kingdom)
Aims: The audience will be updated on current and future European research initiatives/strategies in the area. It involves multidisciplinary research and the aim is to highlight how this is being managed in the global effort to address the issues surrounding the ever-increasing, everyday use of engineered nanomaterials. The audience will then learn about studies of the pulmonary effects of some of these materials, specifically on the immune system and the inflammatory, genotoxic and carcinogenic effects.
Bionanosciences and the lung: a European perspective
K. Dawson (Dublin, Ireland)
No content made available
No content made available
Modulation of T-cell responses by nanoparticles
C. Von Garnier (Bern, Switzerland)
No content made available
No content made available
Genotoxic effects of nanoparticles: new perspectives
R. Schins (Dusseldorf, Germany)
No content made available
No content made available
Nanoparticles for cancer therapy
A. Jordan (Berlin, Germany)
No content made available
No content made available